| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.23 | 0.0004 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |